The $650 central target is an independently calculated mean of seven verified targets, not an official published consensus. The figures reviewed include Stifel at $472 (Nathan Jones, November 2026), Citi at $505 (John Godyn, November 2026), Piper Sandler at $586 (Clarke Jeffries, October 2026), Morgan Stanley at $625 (Kristine Liwag, November 2026), Guggenheim at $674 (November 2026), Deutsche Bank at $801 (August 2026), and Robert W. Baird at $870 (May 2026). The low-to-high range of roughly $472 to $870 is unusually wide, which signals meaningful divergence rather than a tightly clustered view.
The analyst consensus skews toward a "Moderate Buy" with more Buy/Overweight ratings than Holds and no Sell ratings, but the recent trend has been distinctly cautious. In October and November 2026, several firms lowered their targets: Morgan Stanley moved from $860 to $625, Guggenheim from $786 to $674, Citi from $622 to $505, and Stifel from $518 to $472. The two highest targets (Deutsche Bank and Baird) predate this round of reductions and may reflect older, more optimistic assumptions. This pattern indicates analysts are trimming expectations on valuation and multiple, not on the company's operational momentum. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how recent revisions align with technical shifts.
Curtiss-Wright (NYSE: CW) is a diversified industrial and defense supplier serving aerospace, defense-electronics, and naval-and-power (including commercial nuclear) markets. At a latest close of $472.06, the stock sits well below its 52-week high of $808.16 but above its 52-week low of $432.70. Reaching $650 implies roughly a 38% advance — a substantial move that would require both sustained earnings delivery and some recovery in the valuation multiple, rather than a modest drift higher.
The path is complicated by the stock's recent decline of more than 40% from its high. While the company's fundamentals have been strengthening — third-quarter 2026 adjusted diluted EPS rose 16% to $3.94, and backlog reached $4.6 billion, up 12% year to date — the share price has de-rated, suggesting investors have been unwilling to pay the premium multiple the shares previously commanded.
The most credible supports are operational. Management raised full-year 2026 guidance to EPS of $15.40–$15.60 and revenue growth of 8%–10%, implying revenue of roughly $3.795–$3.84 billion, after a strong third quarter. A growing backlog and exposure to rising defense budgets and a commercial nuclear resurgence (including AP1000-related opportunities) provide a multi-year demand narrative. Continued share repurchases and a modest dividend round out a shareholder-friendly capital-return program. If these drivers convert into sustained EPS growth and the multiple stabilizes, the shares have a fundamental foundation from which to rebuild toward higher levels.
The clearest obstacle is valuation and sentiment. Even after the pullback, the stock trades near roughly 30 times trailing earnings — a premium multiple that leaves little room for disappointment. The wave of recent analyst price target cuts shows Wall Street is resetting expectations, and the two highest targets in the range are among the oldest. Additional risks include potential slowdowns in defense procurement, delays in nuclear programs, supply-chain or execution issues, and broader macroeconomic or rate-driven pressure on high-multiple industrials. If multiple compression continues, the stock could remain well below $650 even with solid operating results.
Durably relevant levels include the 52-week low near $432.70, which now serves as the primary support level, and the psychological $500 mark just above the current price. On the upside, the cluster of recently lowered targets around $586–$674 and the prior breakdown zone near $700–$800 represent potential resistance levels. The stock's long-term structure has shifted from an uptrend to a consolidation near the bottom of its 52-week range, meaning any move toward $650 would first require reclaiming and holding levels the stock surrendered during its recent decline. From what I see, the AI Daily Buy/Sell Signals can help flag when momentum starts to shift at these key levels.
Analyst targets generally reflect a research horizon of about 12 months, though individual firms differ, and the age of several targets here (May and August 2026) underscores that this is not a uniform timeline. Investors weighing the $650 question should watch quarterly earnings and guidance updates, order and backlog trends across the defense-electronics and naval/nuclear segments, any further analyst revisions or rating changes, defense-budget developments, and progress on commercial nuclear programs. Shifts in the valuation multiple relative to peers will matter as much as the raw earnings numbers. One thing that stands out is how quickly sentiment can change around defense names like this.
I often turn to Tickeron’s AI Daily Buy/Sell Signals when tracking names that have seen sharp swings and frequent revisions. The tool applies artificial intelligence to monitor thousands of stocks and ETFs in real time, generating Buy, Sell, or Hold signals based on technical behavior and changing market conditions. For a stock like Curtiss-Wright (NYSE: CW), this kind of automated monitoring can complement fundamental work by highlighting when trends may be shifting, allowing investors to manage positions with an additional layer of data-driven insight rather than relying solely on manual review.
The $650 central target — an average of seven verified analyst targets spanning $472 to $870 — implies roughly 38% upside from the latest close of $472.06. Achieving it would require not only continued operational strength, including sustained EPS growth and backlog conversion, but also a stabilization or recovery in the valuation multiple after a steep de-rating. The supporting case rests on raised guidance, a growing backlog, and long-horizon defense and nuclear demand, while the opposing case centers on a premium valuation and a cluster of recent target reductions. Given the wide dispersion among analysts, $650 should be read as a directional midpoint rather than a precise price forecast. Investors should monitor earnings, guidance, analyst revisions, and defense-budget signals rather than treat any single target as a certainty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 37 cases where CW's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 73%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CW's RSI Oscillator exited the oversold zone, 8 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 49 cases where CW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for CW just turned positive on November 09, 2026. Looking at past instances where CW's MACD turned positive, the stock continued to rise in 33 of 48 cases over the following month. The odds of a continued upward trend are 69%.
Following a +11.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where CW advanced for three days, in 255 of 373 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CW as a result. In 58 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
The Aroon Indicator for CW entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 47 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.180) is normal, around the industry mean (5.050). P/E Ratio (31.723) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (1.650) is also within normal values, averaging (3.110). Dividend Yield (0.002) settles around the average of (0.055) among similar stocks. P/S Ratio (5.811) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. CW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of high tech, critical function products, systems and services to the commercial, industrial, defense and power markets
Industry AerospaceDefense